Yunhong Huang
1PUBLICATIONS
2CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (1)
Sort by Publication Date:
|Jul 20, 2022
Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera® ) in combination with CHOP in patients with previously untreated CD20-positive diffuse large B-cell lymphoma: A randomized, single-blind, phase III clinical trial.Yuankai Shi, Qingyuan Zhang, Xiaonan Hong
Pageof 1
